BlackRock’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $82.6M | Sell |
1,936,502
-1,247,098
| -39% | -$55.7M | ﹤0.01% | 2341 |
|
|
2026
Q1 | $153M | Sell |
3,183,600
-2,162,018
| -40% | -$101M | ﹤0.01% | 1831 |
|
|
2025
Q4 | $259M | Sell |
5,345,618
-233,118
| -4% | -$11.6M | ﹤0.01% | 1518 |
|
|
2025
Q3 | $263M | Buy |
5,578,736
+109,306
| +2% | +$5.28M | ﹤0.01% | 1502 |
|
|
2025
Q2 | $264M | Sell |
5,469,430
-1,079,865
| -16% | -$55.2M | 0.01% | 1445 |
|
|
2025
Q1 | $363M | Sell |
6,549,295
-1,141,251
| -15% | -$61.8M | 0.01% | 1226 |
|
|
2024
Q4 | $371M | Sell |
7,690,546
-2,647,802
| -26% | -$135M | 0.01% | 1283 |
|
|
2024
Q3 | $596M | Buy |
10,338,348
+230,742
| +2% | +$12.5M | 0.01% | 951 |
|
|
2024
Q2 | $490M | Sell |
10,107,606
-236,288
| -2% | -$11.4M | 0.01% | 1021 |
|
|
2024
Q1 | $503M | Buy |
10,343,894
+50,239
| +0.5% | +$2.45M | 0.01% | 1033 |
|
|
2023
Q4 | $512M | Buy |
10,293,655
+487,140
| +5% | +$23.8M | 0.01% | 987 |
|
|
2023
Q3 | $526M | Buy |
9,806,515
+167,746
| +2% | +$8.94M | 0.02% | 860 |
|
|
2023
Q2 | $520M | Sell |
9,638,769
-409,087
| -4% | -$22M | 0.01% | 915 |
|
|
2023
Q1 | $547M | Buy |
10,047,856
+249,619
| +3% | +$12.1M | 0.02% | 854 |
|
|
2022
Q4 | $475M | Sell |
9,798,237
-613,381
| -6% | -$26.9M | 0.01% | 918 |
|
|
2022
Q3 | $396M | Sell |
10,411,618
-2,566,602
| -20% | -$114M | 0.01% | 965 |
|
|
2022
Q2 | $649M | Sell |
12,978,220
-87,036
| -0.7% | -$4.62M | 0.02% | 696 |
|
|
2022
Q1 | $671M | Sell |
13,065,256
-56,027
| -0.4% | -$2.89M | 0.02% | 776 |
|
|
2021
Q4 | $657M | Sell |
13,121,283
-903,687
| -6% | -$44.7M | 0.02% | 826 |
|
|
2021
Q3 | $676M | Sell |
14,024,970
-513,478
| -4% | -$26.1M | 0.02% | 772 |
|
|
2021
Q2 | $766M | Sell |
14,538,448
-559,939
| -4% | -$29.2M | 0.02% | 721 |
|
|
2021
Q1 | $747M | Buy |
15,098,387
+1,348,956
| +10% | +$64.8M | 0.02% | 729 |
|
|
2020
Q4 | $668M | Buy |
13,749,431
+314,656
| +2% | +$15.5M | 0.02% | 710 |
|
|
2020
Q3 | $674M | Sell |
13,434,775
-493,424
| -4% | -$25.4M | 0.02% | 602 |
|
|
2020
Q2 | $711M | Buy |
13,928,199
+595,353
| +4% | +$28.9M | 0.03% | 542 |
|
|
2020
Q1 | $583M | Buy |
13,332,846
+4,639,131
| +53% | +$222M | 0.03% | 544 |
|
|
2019
Q4 | $436M | Buy |
8,693,715
+4,469,026
| +106% | +$209M | 0.02% | 901 |
|
|
2019
Q3 | $196M | Buy |
4,224,689
+2,780,646
| +193% | +$120M | 0.01% | 1420 |
|
|
2019
Q2 | $62.5M | Sell |
1,444,043
-117,982
| -8% | -$5.02M | ﹤0.01% | 2198 |
|
|
2019
Q1 | $69.2M | Sell |
1,562,025
-838,184
| -35% | -$35.9M | ﹤0.01% | 2100 |
|
|
2018
Q4 | $104M | Sell |
2,400,209
-614,138
| -20% | -$27.1M | 0.01% | 1772 |
|
|
2018
Q3 | $135M | Sell |
3,014,347
-313,833
| -9% | -$13.4M | 0.01% | 1759 |
|
|
2018
Q2 | $133M | Buy |
3,328,180
+22,425
| +0.7% | +$883K | 0.01% | 1750 |
|
|
2018
Q1 | $132M | Buy |
3,305,755
+250,689
| +8% | +$10.4M | 0.01% | 1645 |
|
|
2017
Q4 | $131M | Buy |
3,055,066
+134,115
| +5% | +$6.18M | 0.01% | 1676 |
|
|
2017
Q3 | $145M | Buy |
2,920,951
+685,529
| +31% | +$33.2M | 0.01% | 1592 |
|
|
2017
Q2 | $107M | Buy |
2,235,422
+720,523
| +48% | +$34.4M | 0.01% | 1750 |
|
|
2017
Q1 | $68.5M | Buy |
1,514,899
+1,514,703
| +772,808% | +$64.3M | ﹤0.01% | 2031 |
|
|
2016
Q4 | $8K | Buy |
+196
| New | +$7.72K | ﹤0.01% | 3445 |
|
|
2015
Q1 | – | Sell |
-9,024
| Closed | -$412K | – | 3179 |
|
|
2014
Q4 | $412K | Sell |
9,024
-3,257
| -27% | -$158K | ﹤0.01% | 1370 |
|
|
2014
Q3 | $693K | Sell |
12,281
-561
| -4% | -$30.1K | ﹤0.01% | 1288 |
|
|
2014
Q2 | $683K | Buy |
12,842
+484
| +4% | +$25.7K | ﹤0.01% | 1281 |
|
|
2014
Q1 | $646K | Buy |
12,358
+10,146
| +459% | +$514K | ﹤0.01% | 1294 |
|
|
2013
Q4 | $119K | Hold |
2,212
| – | – | ﹤0.01% | 1713 |
|
|
2013
Q3 | $112K | Hold |
2,212
| – | – | ﹤0.01% | 1631 |
|
|
2013
Q2 | $114K | Buy |
+2,212
| New | +$118K | ﹤0.01% | 1630 |
|
Other funds holding SNY
MIP
BIP
BlackRock's SNY Position: Q2 2026 in Review
BlackRock reduced its Sanofi (SNY) stake by 39% in Q2 2026, selling an estimated $55.7M and leaving 1,936,502 shares worth $82.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2341.
BlackRock first reported a position in SNY in Q2 2013 and has held it in 46 quarters since. The position peaked at $766M in Q2 2021. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- BlackRock held 1,936,502 shares of Sanofi worth $82.6M as of Q2 2026.
- BlackRock sold 1,247,098 Sanofi shares in Q2 2026, an estimated $55.7M.
- Sanofi made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2341 holding.
- BlackRock first reported a position in Sanofi in Q2 2013 and has held it in 46 quarters since.
- BlackRock's Sanofi position peaked at $766M in Q2 2021.
- 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.